It expands patient options for viewing real-time CGM data (phone or receiver or both) and takes advantage of the smartphone’s many assets to deliver a stronger patient experience (more customizable alarms, better screen, cloud connection).
In much of the US, people now expect things to work right out of the box with a world-class user experience. But expectations have also risen markedly in that time. The data can also be viewed on a CGM receiver alone (e.g., for those with an Android phone).ĭexcom’s G5 is a landmark device approval for the FDA, and a sign of how tremendously far CGM and connectivity have come since Steve Jobs introduced the iPhone in 2007 (we were using the first-gen Dexcom STS!). G5 takes the same accurate G4 continuous glucose sensor, adds Bluetooth to a new on-body transmitter, and introduces a new iPhone/iPod Touch app for viewing the real-time data and getting notifications on the phone. Well, what seemed impossible five years ago is now available.
Sending continuous glucose monitoring (CGM) data from a sensor on the body straight to a phone – no receiver required? The FDA would never approve it! Twitter summary: Dexcom G5 CGM: expands options for viewing data (app, receiver, both), customizable alarms, better data analysis, maintains leading accuracyįive years ago, the concept of Dexcom’s G5 system seemed utterly impossible.